The bad news is it was on bardoxolone. Tweetorial catch-up here.
This week, we will discuss the phosphate targets in dialysis. Are you aiming for HIgh or Low?
This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).
This week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD.
Summary of the CAPTIVATE platform which will be a twitter spaces discussion
The bad news is it was on bardoxolone. Tweetorial catch-up here.
✳️ #TenTweetNephJC ✳️
— Nephrology Journal Club (@NephJC) January 28, 2023
This week CARDINAL - the largest ever RCT in patients with Alport Syndrome 🧵👇 pic.twitter.com/wrAxJoz1GJ